Jean Menotti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jean Menotti has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Francis Derouin
Departments of Parasitology-Mycology,1 Nephrology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris and Paris-Diderot University, Paris, France,2 Section Parasitology, Department of Medical Microbiology, Academic Medical Center, Amsterdam, Netherlands3
4 shared publicationsClaudine Sarfati
Departments of Parasitology-Mycology,1 Nephrology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris and Paris-Diderot University, Paris, France,2 Section Parasitology, Department of Medical Microbiology, Academic Medical Center, Amsterdam, Netherlands3
3 shared publications- Bruno Cassinat
Université Paris Cité, APHP, Hôpital Saint-Louis, Laboratoire de Biologie Cellulaire, Paris, France
2 shared publications Jean-Michel Molina
Laboratory of Parasitology-Mycology,1 Department of Nuclear Medicine,2 Department of Infectious Diseases, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris,3 EA-3520, Faculté de Médecine Lariboisière-Saint-Louis, Université Paris 7, Paris, France4
2 shared publications- Alexandre Alanio
Laboratory of Mycology-Parasitology, Saint-Louis Hospital
1 shared publication André Baruchel
Departments of Pediatric Hematology, and Radiology, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris and University of Paris , France
1 shared publication
Latest Publications
- 1 July 2010
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (7) , 2651-2653
Disseminated Infection with a New Genovar of Encephalitozoon cuniculi in a Renal Transplant Recipient
Disseminated microsporidiosis is a life-threatening opportunistic infection. Here, we report about a previously undescribed genovar of Encephalitozoon cuniculi causing disseminated infection in a non-HIV-infected renal transplant recipient. Disseminated microsporidiosis must be considered in the differential diagnosis of chronic fever in renal allograft recipients, even those without urinary symptoms.
- 1 July 2010
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (7) , 2651-2653
Disseminated Infection with a New Genovar of Encephalitozoon cuniculi in a Renal Transplant Recipient
Disseminated microsporidiosis is a life-threatening opportunistic infection. Here, we report about a previously undescribed genovar of Encephalitozoon cuniculi causing disseminated infection in a non-HIV-infected renal transplant recipient. Disseminated microsporidiosis must be considered in the differential diagnosis of chronic fever in renal allograft recipients, even those without urinary symptoms.
- Open Access
- 1 April 2010
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 16 (4) , 363-368
Evaluation of a new 5'-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat
- 1 April 2010
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 16 (4) , 363-368
Open AccessEvaluation of a new 5'-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat
- Open Access
- 15 May 2008
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (10) , e116-e118
Invasive Pulmonary Infection Due toTrichoderma longibrachiatumMimicking Invasive Aspergillosis in a Neutropenic Patient Successfully Treated with Voriconazole Combined with Caspofungin
Trichoderma longibrachiatum, a filamentous fungus, was recently described as an emerging pathogen in immunocompromised patients. Here, we report the
- 15 May 2008
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (10) , e116-e118
Open AccessInvasive Pulmonary Infection Due toTrichoderma longibrachiatumMimicking Invasive Aspergillosis in a Neutropenic Patient Successfully Treated with Voriconazole Combined with Caspofungin
Trichoderma longibrachiatum, a filamentous fungus, was recently described as an emerging pathogen in immunocompromised patients. Here, we report the
- Open Access
- 1 June 2005
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (6) , 2362-2366
Inhibitory Activity of Human Immunodeficiency Virus Aspartyl Protease Inhibitors against Encephalitozoon intestinalis Evaluated by Cell Culture-Quantitative PCR Assay
Immune reconstitution might not be the only factor contributing to the low prevalence of microsporidiosis in human immunodeficiency virus (HIV)-infected patients treated with protease inhibitors, as these drugs may exert a direct inhibitory effect against fungi and protozoa. In this study, we developed a cell culture-quantitative PCR assay to quantify Encephalitozoon intestinalis growth in U-373-MG human glioblastoma cells and used this assay to evaluate the activities of six HIV aspartyl protease inhibitors against E. intestinalis . A real-time quantitative PCR assay targeted the E. intestinalis small-subunit rRNA gene. HIV aspartyl protease inhibitors were tested over serial concentrations ranging from 0.2 to 10 mg/liter, with albendazole used as a control. Ritonavir, lopinavir, and saquinavir were able to inhibit E. intestinalis growth, with 50% inhibitory concentrations of 1.5, 2.2, and 4.6 mg/liter, respectively, whereas amprenavir, indinavir, and nelfinavir had no inhibitory effect. Pepstatin A, a reference aspartyl protease inhibitor, could also inhibit E. intestinalis growth, suggesting that HIV protease inhibitors may act through the inhibition of an E. intestinalis -encoded aspartyl protease. These results showed that some HIV protease inhibitors can inhibit E. intestinalis growth at concentrations that are achievable in vivo and that the real-time quantitative PCR assay that we used is a valuable tool for the in vitro assessment of the activities of drugs against E. intestinalis .
- 1 June 2005
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (6) , 2362-2366
Open AccessInhibitory Activity of Human Immunodeficiency Virus Aspartyl Protease Inhibitors against Encephalitozoon intestinalis Evaluated by Cell Culture-Quantitative PCR Assay
Immune reconstitution might not be the only factor contributing to the low prevalence of microsporidiosis in human immunodeficiency virus (HIV)-infected patients treated with protease inhibitors, as these drugs may exert a direct inhibitory effect against fungi and protozoa. In this study, we developed a cell culture-quantitative PCR assay to quantify Encephalitozoon intestinalis growth in U-373-MG human glioblastoma cells and used this assay to evaluate the activities of six HIV aspartyl protease inhibitors against E. intestinalis . A real-time quantitative PCR assay targeted the E. intestinalis small-subunit rRNA gene. HIV aspartyl protease inhibitors were tested over serial concentrations ranging from 0.2 to 10 mg/liter, with albendazole used as a control. Ritonavir, lopinavir, and saquinavir were able to inhibit E. intestinalis growth, with 50% inhibitory concentrations of 1.5, 2.2, and 4.6 mg/liter, respectively, whereas amprenavir, indinavir, and nelfinavir had no inhibitory effect. Pepstatin A, a reference aspartyl protease inhibitor, could also inhibit E. intestinalis growth, suggesting that HIV protease inhibitors may act through the inhibition of an E. intestinalis -encoded aspartyl protease. These results showed that some HIV protease inhibitors can inhibit E. intestinalis growth at concentrations that are achievable in vivo and that the real-time quantitative PCR assay that we used is a valuable tool for the in vitro assessment of the activities of drugs against E. intestinalis .
- Open Access
- 1 November 2003
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (11) , 5313-5316
Comparison of PCR-Enzyme-Linked Immunosorbent Assay and Real-Time PCR Assay for Diagnosis of an Unusual Case of Cerebral Toxoplasmosis in a Stem Cell Transplant Recipient
A PCR-enzyme-linked immunosorbent assay and a real-time PCR assay were compared for diagnosis and follow-up of cerebral toxoplasmosis in a stem cell transplant recipient. The sensitivity of detection was similar for both assays but was higher when the assays were performed on buffy coat rather than on whole blood or serum.
- 1 November 2003
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (11) , 5313-5316
Open AccessComparison of PCR-Enzyme-Linked Immunosorbent Assay and Real-Time PCR Assay for Diagnosis of an Unusual Case of Cerebral Toxoplasmosis in a Stem Cell Transplant Recipient
A PCR-enzyme-linked immunosorbent assay and a real-time PCR assay were compared for diagnosis and follow-up of cerebral toxoplasmosis in a stem cell transplant recipient. The sensitivity of detection was similar for both assays but was higher when the assays were performed on buffy coat rather than on whole blood or serum.
- Open Access
- 1 April 2003
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (4) , 1410-1413
Development of a Real-Time PCR Assay for Quantitative Detection of Encephalitozoon intestinalis DNA
A new real-time PCR assay for quantitation of Encephalitozoon intestinalis DNA was developed which used a Taq Man fluorescent probe for specific detection. Serial dilutions of E. intestinalis spore suspensions obtained from tissue culture were used as external standards. The detection limit of the technique was 20 spores per ml, with a good interassay reproducibility (coefficient of variation of 7.1% for the suspension containing 20 spores/ml, 5.0% for the suspension containing 75 spores/ml and below 3.5% for higher concentrations). Quantitative detection of E. intestinalis DNA was similar whether the serial dilutions of spores were made in distilled water or in a stool suspension, allowing the use of the assay for stool specimens. The assay was then applied to 14 clinical specimens from 8 immunocompromised patients with proven E. intestinalis infection. The quantitation of the parasitic burden was achieved in stools, blood, urine, tissue biopsies, and bronchopulmonary specimens. The highest parasitic burdens were noted in stools, urine, and bronchopulmonary specimens, reaching 10 5 to 10 6 spores/g or ml. Dissemination of the infection was also evidenced in some patients by demonstration of E. intestinalis DNA in blood and serum. We conclude that real-time PCR is a valuable tool for quantitation of E. intestinalis burden in clinical specimens.
- 1 April 2003
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (4) , 1410-1413
Open AccessDevelopment of a Real-Time PCR Assay for Quantitative Detection of Encephalitozoon intestinalis DNA
A new real-time PCR assay for quantitation of Encephalitozoon intestinalis DNA was developed which used a Taq Man fluorescent probe for specific detection. Serial dilutions of E. intestinalis spore suspensions obtained from tissue culture were used as external standards. The detection limit of the technique was 20 spores per ml, with a good interassay reproducibility (coefficient of variation of 7.1% for the suspension containing 20 spores/ml, 5.0% for the suspension containing 75 spores/ml and below 3.5% for higher concentrations). Quantitative detection of E. intestinalis DNA was similar whether the serial dilutions of spores were made in distilled water or in a stool suspension, allowing the use of the assay for stool specimens. The assay was then applied to 14 clinical specimens from 8 immunocompromised patients with proven E. intestinalis infection. The quantitation of the parasitic burden was achieved in stools, blood, urine, tissue biopsies, and bronchopulmonary specimens. The highest parasitic burdens were noted in stools, urine, and bronchopulmonary specimens, reaching 10 5 to 10 6 spores/g or ml. Dissemination of the infection was also evidenced in some patients by demonstration of E. intestinalis DNA in blood and serum. We conclude that real-time PCR is a valuable tool for quantitation of E. intestinalis burden in clinical specimens.